5 completed, 1 not yet recruiting, 1 recruiting. 7 Phase 2, 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 7 | Completed 5, Not yet recruiting 1, Recruiting 1 |
| Phase 1 | 2 | Completed 1, Recruiting 1 |
Follow IVIEW Therapeutics Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Evaluate the Efficacy And Safety of IVIEW-1201 In the Treatment of Fungal Keratitis IVIEW-1201, NATACYN® - Fungal Keratitis | Phase 2 | Not yet recruiting | IVIEW Therapeutics Inc. | 60 | 2026-08-01 | 2025-10-15 |
| GVB-2001 Gene Therapy Via Intracameral Injection for the Treatment of Primary Open Angle Glaucoma GVB-2001-high dose, GVB-2001-low dose - Primary Open-Angle Glaucoma (POAG) | Phase 1 / Phase 2 | Recruiting | IVIEW Therapeutics Inc. | 6 | 2025-11-19 | 2026-05-04 |
| Phase 2b Controlled Study of Dosing Techniques - Part B IVW-1001 Ophthalmic Eyelid Wipe 0.2%, IVW-1001 Ophthalmic Eyelid Wipe 0.4% - Dry Eye | Phase 2 | Completed | IVIEW Therapeutics Inc. | 15 | 2025-09-08 | 2026-03-27 |
| Phase 2b Controlled Study IVW-1001 Ophthalmic Eyelid Wipe - Dry Eye Disease | Phase 2 | Completed | IVIEW Therapeutics Inc. | 30 | 2025-08-20 | 2026-03-27 |
| IVW-1001 Phase 1/2 in Subjects With Dry Eye Disease IVW-1001 Ophthalmic Eyelid Wipe 0.1%, IVW-1001 Ophthalmic Eyelid Wipe 0.2%, IVW-1001 Placebo - Dry Eye Disease | Phase 1 / Phase 2 | Completed | IVIEW Therapeutics Inc. | 150 | 2024-06-25 | 2026-02-12 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis IVIEW-1201, Placebo - Adenoviral Conjunctivitis | Phase 2 | Completed | IVIEW Therapeutics Inc. | 135 | 2023-02-20 | 2025-10-15 |
| Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis IVIEW-1201, Ofloxacin Eye Drops - Acute Bacterial Conjunctivitis | Phase 2 | Completed | IVIEW Therapeutics Inc. | 129 | 2023-01-05 | 2025-12-02 |
Dry Eye Syndromes (3) · Glaucoma (1) · Glaucoma, Open-Angle (1) · Night Blindness, Congenital Stationary, Autosomal Dominant 1 (1)
Natamycin (1)
United States (3) · China (2) · India (1)
Bo Liang, PhD (1) · Peirong Lu, MD (1)